Haleon Plc Form 6-K Summary
Business Context and Reporting Period
This Form 6-K filing by Haleon Plc, a global leader in consumer health, covers the month of September 2024. The report specifically details a transaction in the company's own shares executed on September 26, 2024, under a share buyback programme announced on August 1, 2024.
Key Financial Metrics
The filing does not provide revenue, profit, cash flow, margin, debt, or liquidity figures. It focuses exclusively on share repurchase activity:
- Shares Purchased: 508,000 ordinary shares for cancellation.
- Highest Price Paid: 394.00 pence per share.
- Lowest Price Paid: 387.90 pence per share.
- Volume Weighted Average Price: 390.3223 pence per share.
- Post-Transaction Share Capital: 9,113,887,197 ordinary shares.
Material Changes
The primary material change reported is the reduction of the company's registered share capital following the cancellation of 508,000 shares. The filing does not provide comparative financial data against prior periods.
Guidance, Outlook, and Risks
The filing contains no forward-looking guidance, management commentary on financial performance, or discussion of risks and contingencies. It serves as a regulatory disclosure of a specific capital transaction in compliance with the Market Abuse Regulation (Article 5s(1)(b)).
Investor Verification Checklist
- Verify the total number of shares repurchased to date under the August 2024 Buyback Programme.
- Confirm the current market price of Haleon shares relative to the 390.32 pence average purchase price.
- Review the full trade breakdown available via the London Stock Exchange link provided in the filing.
- Check subsequent filings for updates on the remaining authorized buyback amount.